More than 99 percent of cervical cancers are caused by persistent high-risk HPV infection 1 Cervical cancer is nearly 100 percent preventable with proper HPV vaccination, screening and treatment; ...
Roche announced the launch of three molecular PCR diagnostic test panels to simultaneously detect and differentiate common respiratory pathogens: influenza A, influenza B and respiratory syncytial ...
The new cobas 6800/8800 systems 2.0 enhances throughput, run flexibility, enables sample prioritisation and is available as an upgrade to existing systems in healthcare settings around the world.
New TAGS (Temperature-Activated Generation of Signal) technology enables up to 15 targets to be detected simultaneously in a single patient sample on the high throughput molecular diagnostic analysers ...
(RTTNews) - Biopharmaceutical company Roche Holding AG (RHHBY), announced on Tuesday that its cobas HPV test for use on the cobas 6800/8800 Systems has been awarded the World Health Organization (WHO) ...
Used with the cobas ® 5800, 6800 and 8800 systems, cobas Respiratory 4-flex simultaneously detects and differentiates the four most common respiratory viruses, helping to ensure confidence in ...
Roche, a global pioneer in pharmaceuticals and diagnostics, announced that the US Food and Drug Administration (FDA) has provided approval to initiate collection and testing of blood samples for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results